AI is enhancing clinician precision, says Philips North America CEO

Deep News
06/10

A survey sponsored by Royal Philips NV indicates that artificial intelligence is aiding in the improvement of patient care accuracy and, in some instances, saving time and costs, according to the CEO of the company's North American division.

Jeff DiLullo, the CEO of Philips North America, noted that over time, this technology will transform the role of clinicians in healthcare, specifically highlighting gains in labor productivity.

"The median number of additional patients they can see per week is five," DiLullo stated. "This has economic implications for the healthcare system."

The Philips "Future Health Index" survey was conducted by research consultancy Vitreous World between February and April, covering respondents in 10 countries, including 2,011 clinicians and 20,085 patients.

Approximately 30% of the responding physicians reported that AI has already helped them save on their budgets.

Among clinicians, 27% said AI helped them identify potential medical errors at least three times in the past three months, while 36% reported that AI increased their weekly patient capacity. However, 77% of the surveyed clinicians indicated that AI training is either unavailable, limited, or inconsistent.

The Netherlands-based Royal Philips NV stated that healthcare professionals primarily use artificial intelligence for administrative tasks like data organization and scheduling, with more complex decision-making remaining the responsibility of clinicians.

Patients are also increasingly turning to AI for health advice, though previous research has shown the technology is not more helpful than other methods when making medical decisions.

Health insurers, such as Centene, have previously expressed dissatisfaction with AI use in healthcare systems, claiming that its aggressive or improper application has led to increased reimbursement payments.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10